1. Construction, Characterization and Application of Recombinant Porcine Deltacoronavirus Expressing Nanoluciferase.
- Author
-
Fang, Puxian, Zhang, Huichang, Sun, He, Wang, Gang, Xia, Sijin, Ren, Jie, Zhang, Jiansong, Tian, Liyuan, Fang, Liurong, and Xiao, Shaobo
- Subjects
- *
VIRAL tropism , *BACTERIAL artificial chromosomes , *HIGH throughput screening (Drug development) , *REVERSE genetics , *ANTIVIRAL agents , *VACCINE effectiveness - Abstract
Porcine deltacoronavirus (PDCoV), an emerging enteropathogenic coronavirus, causes diarrhoea in suckling piglets and has the potential for cross-species transmission. No effective PDCoV vaccines or antiviral drugs are currently available. Here, we successfully generated an infectious clone of PDCoV strain CHN-HN-2014 using a combination of bacterial artificial chromosome (BAC)-based reverse genetics system with a one-step homologous recombination. The recued virus (rCHN-HN-2014) possesses similar growth characteristics to the parental virus in vitro. Based on the established infectious clone and CRISPR/Cas9 technology, a PDCoV reporter virus expressing nanoluciferase (Nluc) was constructed by replacing the NS6 gene. Using two drugs, lycorine and resveratrol, we found that the Nluc reporter virus exhibited high sensibility and easy quantification to rapid antiviral screening. We further used the Nluc reporter virus to test the susceptibility of different cell lines to PDCoV and found that cell lines derived from various host species, including human, swine, cattle and monkey enables PDCoV replication, broadening our understanding of the PDCoV cell tropism range. Taken together, our reporter viruses are available to high throughput screening for antiviral drugs and uncover the infectivity of PDCoV in various cells, which will accelerate our understanding of PDCoV. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF